Universitätsklinikum Gießen und Marburg (UKGM)

Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer (2026) Van Mackelenbergh MT, Pfarr N, Weber K, Untch M, Solbach C, Schneeweiss A, Jank P, et al. Journal article Non-invasive vessel fractional flow reserve versus fractional flow reserve guidance to revascularize intermediate coronary stenosis (LIPSIA-STRATEGY) trial: study protocol for a randomized controlled trial (2026) Majunke N, Desch S, Kister T, Buske M, Pöss J, Feistritzer HJ, Erbs S, et al. Journal article Radiologic drivers of dysphagia after intracerebral haemorrhage: a flexible endoscopic evaluation of swallowing-guided retrospective analysis on intensive care unit (2026) Hamzic S, Alhaj Omar O, Danielczik L, Gerner ST, Viard M, Bender M, Kraemer HH, et al. Journal article Impact of personalized coaching on the use of digital health interventions for movement therapy in rheumatology: a randomized controlled trial (2026) Binder M, Temiz A, Palm von Alten Blaskowitz PA, Coppers B, Ebner I, Petit P, Vuillerme N, et al. Journal article Stratification of children with myocarditis using radiomics signatures in LGE cardiovascular MRI (2026) Laube AP, Huellebrand M, Ter-Minassian L, Uden T, Schwarzkopf E, Opgen-Rhein B, Anderheiden F, et al. Journal article The Smokerface poster campaign for adolescent smoking prevention in schools: A cluster-randomized controlled trial (2026) Wies C, Messner J, Merl NB, Winterstein JT, Kommoss K, Jakob L, Fahrner HM, et al. Journal article Hybridbildgebung gemeinsam gestalten: Status quo und Perspektiven (2026) Heimer MM, Rischen R, Bayerl N, Ristow I, Umutlu L, Cyran CC, Sadat-Ebrahimi SR, et al. Journal article [177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial (2026) Walter T, Jann H, Ansquer C, Deshayes E, Garcia-Carbonero R, Teulé A, Baum RP, et al. Journal article Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial (2026) Atreya R, Kühbacher T, Vieth M, Jefremow A, Hirschmann S, Waldner M, Fischer S, et al. Journal article Clinical presentation and outcomes of sporadic neuroendocrine neoplasms in young adults (2026) Malczewska-Herman A, Rinke A, Holmager P, Opalińska M, McNamara MG, Netto D, Tesselaar ME, et al. Journal article